Minnesota Daily Digest
SEE OTHER BRANDS

Your daily news update on Minnesota

Minnesota Daily Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Minnesota Daily Digest.

Press releases published on July 14, 2025

Bad Rooster® Food Truck Wins the 2025 Quality Business Award for The Best Caterers in Minnetonka, Minnesota

Bad Rooster® Food Truck Wins the 2025 Quality Business Award for The Best Caterers in Minnetonka, Minnesota

MINNETONKA, MN, UNITED STATES, July 14, 2025 /⁨EINPresswire.com⁩/ -- The 2025 Quality Business Award for The Best Caterers in Minnetonka, Minnesota has been awarded to Bad Rooster® Food Truck. This recognition honors Bad Rooster® Food Truck for its …

Fielo expands B2B commerce loyalty capabilities to help global enterprises accelerate retention and revenue

Fielo expands B2B commerce loyalty capabilities to help global enterprises accelerate retention and revenue

Built on Salesforce, Fielo’s platform gives B2B brands the tools to drive repeat purchases, grow customer lifetime value, and deepen buyer relationships MINNEAPOLIS, MN, UNITED STATES, July 14, 2025 /⁨EINPresswire.com⁩/ -- As global B2B enterprises face …

Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)

Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)

Sanuwave is pleased to announce preliminary revenues of $10.1 million to $10.2 million for the second quarter ended June 30, 2025. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 revenue increased between 41% and 42% compared …

Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042

Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042

MINNEAPOLIS, July 14, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the issuance of U.S. Patent No. 12,350,276 covering the clinical …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service